StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.88−0.08 (-8.24%)

Close on Nov 16, 2026Market cap $13.93MP/E –Yield –

Allarity Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -3939.1%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3939.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-10752.0%–

More Allarity Therapeutics figures

See a number that looks wrong?